Reaction

Brain Abscess reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,494 reports · 110 co-occurring drugs

As of the last recalculation, Brain Abscess appears in 2,494 FAERS reports alongside 110 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 49.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Voriconazole Injection	122	49.2	49.5
Valganciclovir Hydrochloride Powder,	66	46.4	46.6
Anti-Thymocyte Globulin (Rabbit)	41	43.1	43.3
Amphotericin B	63	43.0	43.2
Mycophenilic Acid	102	42.8	43.0
Meropenem	146	40.3	40.4
Posaconazole Delayed-Release	51	39.5	39.7
Tacrolimus Ointment 0.1%	467	38.3	38.4
Tacrolimus Extended-Release Capsules	467	38.2	38.3
Voriconazole	127	36.7	36.9
Valganciclovir	80	36.6	36.7
Valganciclovir Hydrochloride	80	36.6	36.7
Tacrolimus	508	33.7	33.8
Micafungin Sodium	33	32.9	33.0
Mycophenolic Acid	107	29.1	29.2
Basiliximab	40	28.8	28.9
Posaconazole	54	28.3	28.4
Mycophenolate Mofetil	391	28.3	28.4
Mycophenolate Mofetil Hydrochloride	391	28.3	28.3
Ceftriaxone	104	27.6	27.6
Ampicillin	27	27.5	27.6
Ampicillin Sodium	27	27.5	27.6
Ganciclovir Sodium	33	26.4	26.4
Ceftriaxone Sodium	112	25.5	25.5
Amikacin	46	22.9	23.0
Sirolimus	36	22.6	22.7
Rifampicin	27	22.5	22.6
Daspone	25	21.6	21.7
Dapsone Gel, 5%	25	21.6	21.7
Daptomycin	23	21.0	21.0
Obinutuzumab	40	20.6	20.7
Ganciclovir	25	20.6	20.6
Dapsone	25	19.7	19.8
Prednisolone	344	18.3	18.3
Prednisolone Oral	344	18.3	18.3
Prednisolone Oral Solution	344	18.3	18.3
Linezolid	61	17.5	17.5
Busulfan	32	17.2	17.2
Moxifloxacin	28	16.8	16.8
Azacitidine For	36	16.7	16.8
Vancomycin	107	16.1	16.1
Ado-Trastuzumab Emtansine	16	15.9	16.0
Vancomycin Hydrochloride	114	15.1	15.1
Atovaquone	13	13.5	13.6
Metronidazole Topical	75	13.5	13.5
Cefepime	23	13.5	13.5
Pyrazinamide	15	13.4	13.4
Cefepime Hydrochloride	25	13.1	13.1
Gentamicin	20	12.9	12.9
Moxifloxacin Hydrochloride	29	12.1	12.1
Alemtuzumab	27	11.8	11.8
Rifampin	20	11.5	11.5
Metronidazole	84	11.3	11.3
Gentamicin Sulfate	21	11.2	11.2
Azacitidine	38	10.8	10.9
Fludarabine Phosphate	50	10.8	10.8
Dexamethasone Sodium Phosphate	13	10.7	10.7
Cyclophosphamide Injection, Solution	210	10.7	10.7
Cyclophosphamide	210	10.7	10.7
Cyclophosphamide For Injection	210	10.7	10.7
Prednisone	476	9.5	9.5
Terbinafine Hydrochloride	10	9.4	9.4
Cyclosporine	116	9.1	9.1
Methylprednisolone	142	9.0	9.0
Cytarabine	61	8.7	8.7
Itraconazole	12	8.6	8.6
Azathioprine	84	8.2	8.2
Fluconazole	67	8.2	8.2
Melphalan	20	7.4	7.4
Thiotepa	8	7.0	7.0
Pegaspargase	10	6.8	6.8
Melphalan Hydrochloride	20	6.7	6.7
Clindamycin	22	6.5	6.5
Bendamustine Hcl	12	6.5	6.5
Piperacillin Sodium,Tazobactam Sodium	20	6.3	6.3
Isoniazid	12	6.2	6.2
Everolimus Tablets	12	6.0	6.0
Piperacillin And Tazobactam	9	5.9	5.9
Ibrutinib	55	5.8	5.8
Levofloxacin	41	5.8	5.8
Levofloxacin In 5% Dextrose	41	5.8	5.8
Minocycline	8	5.7	5.7
Levetiracetam	89	5.7	5.7
Hydroxychloroquine	48	5.5	5.5
Venetoclax	39	5.4	5.4
Vincristine Sulfate	18	5.2	5.2
Doxorubicin Hydrochloride	20	5.1	5.1
Dexamethasone 1.5 Mg	168	5.1	5.1
Doxorubicin	53	5.0	5.1
Dexamethasone	168	5.0	5.0
Bendamustine Hydrochloride	7	4.9	4.9
Tobramycin Solution	7	4.9	4.9
Levetiracetam In Sodium Chloride	44	4.8	4.8
Levetiracetam Oral	44	4.8	4.8
Levetiracetam Injection	44	4.8	4.8
Temozolomide	12	4.8	4.8
Imatinib	10	4.7	4.7
Tobramycin Sulfate	7	4.7	4.7
Acalabrutinib	6	4.1	4.1
Ixazomib	13	3.8	3.8
Bortezomib	40	3.8	3.8
Nevirapine	4	3.7	3.7
Bosentan	22	3.7	3.7
Baricitinib	4	3.5	3.5
Ivacaftor	3	3.2	3.2
Oseltamivir	3	3.1	3.1
Remdesivir	5	3.1	3.1
Carfilzomib	10	3.0	3.0
Abiraterone	4	2.5	2.5
Ipilimumab	12	2.3	2.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.